|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| TCG Crossover Management LLC
✚
|
|
|---|---|
| CRD # | 311718 |
| SEC # | 801-120001 |
| CIK # | 0001839948 |
| AUM | $1.8 B (2025-03-31) |
| Employees | 17 (59% Investors, 0% Brokers) |
| Phone | 650-924-9424 |
| Address | 705 High St Palo Alto, CA 94301 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| CIK | Period |
|---|---|
| 0001839948 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| CG Oncology Inc | 95.4 | ||
| BCTG Acquisition Corp | 55.0 | ||
| UNUM Therapeutics Inc | 50.0 | ||
| Ocular Therapeutix Inc | 49.4 | ||
| Cidara Therapeutics Inc | 49.0 | ||
| Abivax Sa | 46.3 | ||
| Amylyx Pharmaceuticals Inc | 38.1 | ||
| Centessa Pharmaceuticals PLC | 38.0 | ||
| Fulcrum Therapeutics Inc | 36.1 | ||
| Dyne Therapeutics Inc | 35.9 | ||
| Psivida Corp | 33.6 | ||
| Upstream Bio Inc | 30.8 | ||
| Adventrx Pharmaceuticals Inc | 28.2 | ||
| Magenta Therapeutics Inc | 28.0 | ||
| TYRA Biosciences Inc | 27.7 | ||
| FS Development Corp | 24.6 | ||
| Talaris Therapeutics Inc | 23.6 | ||
| Agios Pharmaceuticals Inc | 23.2 | ||
| Structure Therapeutics Inc | 22.0 | ||
| Xencor Inc | 19.3 | ||
| Silence Therapeutics PLC | 17.6 | ||
| Capnia Inc | 15.6 | ||
| Catabasis Pharmaceuticals Inc | 14.8 | ||
| RAPT Therapeutics Inc | 13.1 | ||
| Imara Inc | 10.0 | ||
| MBX Biosciences Inc | 7.4 | ||
| Nektar Therapeutics | 6.9 | ||
| Vistagen Therapeutics Inc | 5.4 | ||
| Kodiak Sciences Inc | 4.3 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| Other | TCG Crossover Fund II LP | [2024-03-27] | 0.0 | 1,021.1 |
| Other | TCG Crossover Fund I LP | [2021-03-30] | 800.0 | 778.7 |
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 2 | 1.8 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 2 | 1.8 |
| By Discretionary | ||
| Discretionary | 2 | 1.8 |
| Non-Discretionary | 0 | 0.0 |
| Total | 2 | 1.8 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 1.8 | |
| Total | 2 | 1.8 |
| Form D Directors | # Filings | # Firms | 2011 - 2025 |
|---|---|---|---|
| Chen Yu | 24 |
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| 13F-HR | [0001839948] | |
| SC 13G | [0001839948] |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Freedom Funds Management Co
✚
|
CO | 1.8 |
|
Lattice Strategies LLC
✚
|
PA | 1.8 |
|
Swift Creek Real Estate Partners LLC
✚
|
TX | 1.8 |
|
Impactassets Capital Partners PB LLC
✚
|
MD | 1.8 |
|
I80 Group LP
✚
|
NY | 1.8 |
|
Regent Properties LLC
✚
|
CA | 1.8 |
|
Churchill PCIF Advisor LLC
✚
|
NY | 1.8 |
|
UBS Trust Company of Puerto Rico
✚
|
PR | 1.8 |
|
BlueMountain Fuji Management LLC
✚
|
NY | 1.8 |
|
Breakwall Investment Advisor LLC
✚
|
NY | 1.8 |